🔗 Share this article

A shadow market for unlicensed slimming medications is being driven by TikTok fitness influencers and vendors on communication apps, based on new investigations.

Experimental Treatment Gaining Popularity Via Social Media

The experimental drug, which is still in clinical trials, is being advertised by social media influencers for its supposed fat-burning effects. Viewers are urged to contact these accounts privately for source information, while also obtaining promotional offers.

Thriving Commerce on Messaging Platforms

Separately, a flourishing trade exists on Telegram, where groups with thousands of participants share comparison photos, administration instructions and claims of rapid British shipping. Vendors promote the drug there before redirecting buyers to WhatsApp for transactions.

Understanding The Experimental Drug

Retatrutide is an investigational injection created by US drugmaker Eli Lilly. The drug affects three gut hormones – GLP-1, GIP and glucagon. Preliminary studies indicate it could assist patients lose up to 25% of their body weight. Nicknamed the “triple G”, the substance is being promoted online as the successor to Ozempic.

Healthcare Professionals Voice Worries

However, doctors and chemists have cautions that the distribution of what is still an unlicensed medication in the UK is a cause for concern and could result in individuals injecting substances of unknown origin.

Several professionals stated the demand for retatrutide could be linked to the increasing price of licensed slimming products such as Mounjaro.

Legal Position and Enforcement

Selling retatrutide on social media or Telegram is prohibited in the UK, as it is an unlicensed drug that must not be promoted or supplied for personal consumption under the Human Medicines Regulations 2012.

Some content creators attempt to circumvent the rules by calling to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled drug, but promotion and distribution can still violate pharmaceutical, advertising, and customer regulations, risking penalties, prosecution or prison.

Service Response and Content Elimination

Based on TikTok, the service has taken down problematic content and banned related keywords and search suggestions. The organization stated it was dedicated to keeping the service safe and investing in enhancing enforcement strategies.

Digital Marketplace Activities

Investigations also found communities with up to nine thousand members marketing the experimental drug using the platform's integrated search feature, which operates like a public directory. Entering “retatrutide” instantly brings up groups with thousands of users, populated with photos of weight loss, positive testimonials and step-by-step guides for preparing or administering at home.

After moments of joining one community, a vendor posted contact information, where most purchases occur. The vendor provided an instruction manual and promised delivery within 48 hours. When questioned whether the product was genuine, one seller responded: “You can’t be sure.” Another shared a image of a alleged laboratory certificate. Not one inquired about weight, health issues or previous experience.

Item Details and Pricing

Inside these groups, posts show black plastic parcels with postal service stickers, stating to include new batches. One communication stated: “It took eight of us to load them this morning.”

Buyers can choose between powder vials, prepared at residence with sterile water, or pre-filled pens typically sold at £160 for 20mg. When asked how long a injector should be used, vendors give contradictory answers ranging from a several days to “depends on your body”.

Service Oversight and Security Actions

A representative for the messaging service stated it regularly moderated dangerous material on its platform including content that promoted the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”.

Healthcare Professional Cautions

“Individuals are administering substances they cannot confirm. Even if the research behind retatrutide is sound, these digital versions may not include what they claim,” stated a pharmacy expert, the head of pharmaceutical services at a pharmacy service.

A medical professional of Asda Online Doctor connected the increase in interest to recent price rises for authorized weight-loss drugs such as Mounjaro. “With costs increasing, patients are using social media. But fake injections are highly dangerous. You can’t be certain what’s contained or whether the environment they were produced in was clean,” she explained.

Her staff has previously encountered patients harmed by self-injection from unconfirmed suppliers. “We understand the frustration, but buying from messaging apps or communication platforms is gambling with your well-being,” said Wyllie. “These substances could be impure or improperly measured.”

Producer Statement

A spokesperson from Eli Lilly stated the substance was in phase 3 research studies and had not been evaluated or authorized by any regulatory agency globally. “Consequently at this time no one can sell [it] for human use,” they said, adding that any product “misleadingly claiming itself as a company investigational substance not yet authorized … may expose users to possibly significant health risks”.